Sarepta Therapeutics Inc (SRPT) USD0.0001
2.29%- This stock can be held in a
Stocks and Shares ISASell:$130.92
Buy:$131.36
Change:
$3.76 (2.95%)
$3.76 (2.95%)Prices delayed by at least 15 minutes
Sell:$130.92
Buy:$131.36
Change:$3.76 (2.95%)
$3.76 (2.95%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 March 2024 | Kathryn Jean BoorDirector | Sell Tax related | 761 | $122.93 | $93,549.73 | 7,516 |
| 8 March 2024 | Louise Rodino-KlapacChief Level Officer | Sell Tax related | 909 | $123.14 | $111,934.26 | 68,073 |
| 8 March 2024 | Ian Michael EstepanCFO | Sell Tax related | 1,035 | $123.14 | $127,449.90 | 36,164 |
| 8 March 2024 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 3,155 | $123.85 | $390,746.75 | 34,685 |
| 8 March 2024 | Ryan Edward BrownSenior Vice President | Sell Tax related | 899 | $123.14 | $110,702.86 | 28,688 |
| 8 March 2024 | Bilal ArifCTO | Sell Tax related | 472 | $123.14 | $58,122.08 | 25,222 |
| 8 March 2024 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 11,745 | $123.10 | $1,445,809.50 | 22,940 |
| 8 March 2024 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 100 | $122.39 | $12,239.00 | 22,840 |
| 7 March 2024 | Louise Rodino-KlapacChief Level Officer | Sell Tax related | 512 | $120.49 | $61,690.88 | 68,982 |
| 7 March 2024 | Ian Michael EstepanCFO | Sell Tax related | 526 | $120.49 | $63,377.74 | 37,199 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 August 2023 | Michael Andrew ChambersIndependent Director | Buy Regular purchase transaction | 31,570 | $106.26 | $3,354,628.20 | 213,331 |
| 3 November 2023 | Richard Jon BarryDirector | Buy Regular purchase transaction | 40,000 | $78.81 | $3,152,400.00 | 140,000 |
| 11 August 2023 | Michael Andrew ChambersIndependent Director | Buy Regular purchase transaction | 23,686 | $108.05 | $2,559,272.30 | 237,017 |
| 4 August 2023 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 15,000 | $106.72 | $1,600,800.00 | 20,994 |
| 8 March 2024 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 11,745 | $123.10 | $1,445,809.50 | 22,940 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.